Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
428 S Grove St
Ypsilanti, MI 48198Phone+1 734-483-7136Fax+1 734-483-3422
Education & Training
- Rutgers Health/Jersey City Medical CenterResidency, Internal Medicine, 1972 - 1975
- MedStar Franklin Square Medical CenterInternship, Transitional Year, 1971 - 1972
- Dow University of Health SciencesClass of 1968
Certifications & Licensure
- NJ State Medical License Current
- MI State Medical License 1975 - 2025
Publications & Presentations
PubMed
- 24 citationsRecombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant miceAthar H. Siddiqui, Roxanna A. Irani, Yujin Zhang, Yingbo Dai, Sean C. Blackwell
American Journal of Hypertension. 2011-05-01 - 43 citationsRenal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats.Amer C. Hakam, Athar H. Siddiqui, Tahir Hussain
American Journal of Physiology. Renal Physiology. 2006-02-01 - 2 citationsThe Effect of Treatment With Aminoguanidine, an Advanced Glycation End Product Inhibitor, on Streptozotocin-Induced Diabetic Rats and Its Effects on Physiological and ...Ram Mukka R Jogula, Anupama T Row, Athar H Siddiqui
Cureus. 2023-07-01
Press Mentions
- ObvioHealth, RedHill Biopharma Launches First in Kind Remote COVID-19 Therapy TrialMarch 2nd, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: